S. Poser

15.8k total citations · 2 hit papers
145 papers, 10.5k citations indexed

About

S. Poser is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, S. Poser has authored 145 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 42 papers in Pathology and Forensic Medicine and 32 papers in Neurology. Recurrent topics in S. Poser's work include Prion Diseases and Protein Misfolding (69 papers), Multiple Sclerosis Research Studies (40 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (19 papers). S. Poser is often cited by papers focused on Prion Diseases and Protein Misfolding (69 papers), Multiple Sclerosis Research Studies (40 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (19 papers). S. Poser collaborates with scholars based in Germany, United States and Austria. S. Poser's co-authors include Inga Zerr, Thomas Weber, Hans A. Kretzschmar, Walter Schulz‐Schaeffer, Maurizio Pocchiari, Albert Hofman, Annick Alpérovitch, Robert Will, Martin Zeidler and Otto Windl and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

S. Poser

142 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new variant of Creutzfeldt-Jakob disease in the UK

1996 1.8k citations S. Poser et al. profile →
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects

1999 1.0k citations Otto Windl, Inga Zerr et al. Annals of Neurology profile →

Peers

Countries citing papers authored by S. Poser

Since Specialization

Citations

This map shows the geographic impact of S. Poser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Poser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Poser more than expected).

Fields of papers citing papers by S. Poser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Poser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Poser. The network helps show where S. Poser may publish in the future.

Co-authorship network of co-authors of S. Poser

This figure shows the co-authorship network connecting the top 25 collaborators of S. Poser. A scholar is included among the top collaborators of S. Poser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Poser. S. Poser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies 2007 ·Neurodegenerative Diseases ·Brit Mollenhauer, Petra Steinacker, Erik Bahn, Mirko Bibl, Peter Brechlin, Michael G. Schlossmacher, Joseph J. Locascio, Jens Wiltfang, Hans A. Kretzschmar, S. Poser, Claudia Trenkwalder, Markus Otto	62
2	Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt-Jakob disease* 2005 ·Acta Neurologica Scandinavica ·Christian Jacobi, Sönke Arlt, Hansotto Reiber, Ingo M. Westner, H. A. Kretzschmar, S. Poser, Inga Zerr	24
3	Epidemiology and Risk Factors of Transmissible Spongiform Encephalopathies in Man 2004 ·PubMed ·(unknown), S. Poser	5
4	Interferon-?-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis 2003 ·Journal of Neurology ·(unknown), (unknown), (unknown), Andreas Bitsch, Alexander Dressel, Hayrettin Tumani, Timon Bogumil, Bernd Kitze, S. Poser, Frank Weber	40
5	Different binding pattern of antibodies to prion protein on lymphocytes from patients with sporadic Creutzfeldt–Jakob disease 2003 ·Neuroscience Letters ·Peter Ratzka, Susanne Döhlinger, Lukas Cepek, Petra Steinacker, Sönke Arlt, Christian Jacobi, Andreas Schröter, Jens Wiltfang, Hilmar Prange, Hans A. Kretzschmar, S. Poser, Markus Otto	2
6	Iatrogenic Creutzfeldt‐Jakob Disease with Florid Plaques 2003 ·Brain Pathology ·Hans A. Kretzschmar, Shneh Sethi, (unknown), Otto Windl, (unknown), Inga Zerr, S. Poser	34
7	Positron emission tomography with [ 18 F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD) 2002 ·Journal of Neurology ·Karsten Henkel, Inga Zerr, A. Hertel, (unknown), Andreas Schröter, Henriette J. Tschampa, H. Bihl, Ü. Büll, Frank Grünwald, Alexander Drzezga, Jörg Spitz, S. Poser	57
8	C‐reactive protein and IL‐6: new marker proteins for the diagnosis of CJD in plasma? 2001 ·Transfusion ·Dirk Völkel, Klaus F. Zimmermann, Inga Zerr, Thomas Lindner, (unknown), S. Poser, Hans Peter Schwarz	22
9	Diffusionsgewichtetes MRT bei Creutzfeldt-Jakob-Patienten 2000 ·Der Nervenarzt ·(unknown), Michael Finkenstaedt, Inga Zerr, (unknown), S. Poser	21
10	Akinetic mutism as a classification criterion for the diagnosis of Creutzfeldt-Jakob disease 1998 ·Journal of Neurology Neurosurgery & Psychiatry ·Alexander Otto, Inga Zerr, (unknown), (unknown), Christian Riedemann, S. Poser	15
11	Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease 1998 ·Annals of Neurology ·Inga Zerr, Monika Bodemer, Olaf Gefeller, Markus Otto, S. Poser, Jens Wiltfang, Otto Windl, Hans A. Kretzschmar, Thomas Weber	332
12	Erweitertes Krankheitsspektrum humaner spongiformer Enzephalopathien oder Prionkrankheiten 1997 ·Der Nervenarzt ·Thomas Weber, Inga Zerr, Monika Bodemer, S. Poser	2
13	Apolipoprotein E Phenotype Frequency and Cerebrospinal Fluid Concentration Are Not Associated With Creutzfeldt-Jakob Disease 1996 ·Archives of Neurology ·Inga Zerr, Marion Helmhold, S. Poser, Victor W. Armstrong, Thomas Weber	17
14	The use of recombinant antigens in ELISA procedures for the quantification of intrathecally produced HIV-1-specific antibodies 1991 ·Journal of Immunological Methods ·Thomas Weber, (unknown), W. Lüer, (unknown), (unknown), S. Poser, K. Felgenhauer	5
15	Impact of magnetic resonance imaging (MRI) on the epidemiology of MS 1991 ·Acta Neurologica Scandinavica ·S. Poser, Peter C. Scheidt, B. Kitze, W. Lüer, (unknown), (unknown), (unknown)	7
16	Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV 1989 ·Journal of Neurology ·R. Kaiser, Rüdiger Dörries, W. Lüer, S. Poser, H. D. Pohle, K. Felgenhauer, Volker ter Meulen	31
17	Increasing Incidence of Multiple Sclerosis in South Lower Saxony, Germany 1989 ·Neuroepidemiology ·S. Poser, (unknown), (unknown), D Burckhardt, (unknown)	47
18	Chronic HIV encephalitis — I. cerebrospinal fluid diagnosis 1988 ·Journal of Molecular Medicine ·W. Lüer, S. Poser, Thomas Weber, (unknown), D. Eichenlaub, H. D. Pohle, K. Felgenhauer	48
19	[Clinical studies on the habitual abuse of bromoureides]. 1975 ·PubMed ·W. Poser, S. Poser, (unknown)	1
20	[Technique of electronic data processing in a multicenter study on multiple sclerosis--early experience with an optical mark reader form system (author's transl)]. 1973 ·PubMed ·S. Poser, (unknown), Hans‐Jörg Bauer	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact